Janux Therapeutics Inc. (JANX)
27.11
-1.99 (-6.84%)
At close: Mar 31, 2025, 9:38 AM
Janux Therapeutics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 430.61M | 19.2M | 51.43M | 35.58M | 7.81M | 658K |
| Short-Term Investments | 594.57M | 324.82M | 275.59M | 339.38M | n/a | n/a |
| Long-Term Investments | n/a | n/a | 816K | 816K | n/a | n/a |
| Other Long-Term Assets | 3.7M | 3.33M | 1.39M | 392K | -155K | -21K |
| Receivables | n/a | n/a | n/a | n/a | 8M | n/a |
| Inventory | n/a | n/a | -700K | -200K | n/a | n/a |
| Other Current Assets | 8.49M | 5.21M | 5.42M | 4.11M | 498K | n/a |
| Total Current Assets | 1.03B | 349.24M | 332.44M | 377.02M | 16.06M | 658K |
| Property-Plant & Equipment | 24.15M | 27.84M | 29.36M | 1.6M | 155K | 21K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 27.85M | 31.17M | 31.57M | 2.81M | 155K | 21K |
| Total Assets | 1.06B | 380.41M | 364.01M | 379.82M | 16.22M | 679K |
| Account Payables | 4.03M | 2.42M | 2.16M | 2.46M | 428K | 267K |
| Deferred Revenue | n/a | 1.71M | 5.41M | 5.16M | 1.95M | n/a |
| Short-Term Debt | 1.75M | 1.52M | 1.53M | 388K | n/a | 4M |
| Other Current Liabilities | 11.68M | 7.39M | 7.42M | 4.79M | 803K | 360K |
| Total Current Liabilities | 17.46M | 13.03M | 16.51M | 12.8M | 3.18M | 4.63M |
| Long-Term Debt | 21.28M | 23.02M | 49.08M | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | -24.54M | n/a | 21.62M | n/a |
| Total Long-Term Liabilities | 21.28M | 23.02M | 26.76M | 700K | 27.67M | 4M |
| Total Liabilities | 38.73M | 36.06M | 43.27M | 13.5M | 30.86M | 8.62M |
| Total Debt | 23.02M | 24.54M | 25.3M | 194K | n/a | 4M |
| Common Stock | 59K | 46K | 42K | 41K | 1K | 1K |
| Retained Earnings | -237.76M | -168.76M | -110.47M | -47.41M | -14.74M | -7.96M |
| Comprehensive Income | 2.16M | 665K | -1.53M | -270K | -21.62M | -4M |
| Shareholders Equity | 1.02B | 344.35M | 320.74M | 366.33M | -14.64M | -7.94M |
| Total Investments | 594.57M | 324.82M | 275.59M | 339.38M | n/a | n/a |